201 related articles for article (PubMed ID: 31950221)
1. Bufotalin ameliorates experimental Sjögren's syndrome development by inhibiting Th17 generation.
Huang Y; Yang G; Fei J; Wu Y; Yan J
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1977-1985. PubMed ID: 31950221
[TBL] [Abstract][Full Text] [Related]
2. Th17 cells play a critical role in the development of experimental Sjögren's syndrome.
Lin X; Rui K; Deng J; Tian J; Wang X; Wang S; Ko KH; Jiao Z; Chan VS; Lau CS; Cao X; Lu L
Ann Rheum Dis; 2015 Jun; 74(6):1302-10. PubMed ID: 24573745
[TBL] [Abstract][Full Text] [Related]
3. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.
Dean S; Wang CS; Nam K; Maruyama CL; Trump BG; Baker OJ
Rheumatology (Oxford); 2019 Jul; 58(7):1285-1292. PubMed ID: 30877775
[TBL] [Abstract][Full Text] [Related]
5. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
6. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients.
Barrera MJ; Aguilera S; Castro I; Cortés J; Bahamondes V; Quest AFG; Molina C; González S; Hermoso M; Urzúa U; Leyton C; González MJ
J Autoimmun; 2016 Dec; 75():68-81. PubMed ID: 27461470
[TBL] [Abstract][Full Text] [Related]
8. Detection of IFN-γ+IL-17+ cells in salivary glands of patients with Sjögren's syndrome and Mikulicz's disease: Potential role of Th17•Th1 in the pathogenesis of autoimmune diseases.
Nanke Y; Kobashigawa T; Yago T; Kawamoto M; Yamanaka H; Kotake S
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(5):473-477. PubMed ID: 27795505
[TBL] [Abstract][Full Text] [Related]
9. M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.
Abe S; Tsuboi H; Kudo H; Asashima H; Ono Y; Honda F; Takahashi H; Yagishita M; Hagiwara S; Kondo Y; Matsumoto I; Sumida T
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32614803
[TBL] [Abstract][Full Text] [Related]
10. Cytokines in Sjögren's syndrome.
Roescher N; Tak PP; Illei GG
Oral Dis; 2009 Nov; 15(8):519-26. PubMed ID: 19519622
[TBL] [Abstract][Full Text] [Related]
11. cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjögren's syndrome.
Takahashi H; Tsuboi H; Asashima H; Hirota T; Kondo Y; Moriyama M; Matsumoto I; Nakamura S; Sumida T
Clin Exp Immunol; 2017 Oct; 190(1):96-109. PubMed ID: 28621822
[TBL] [Abstract][Full Text] [Related]
12. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
13. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
He J; Zhao J; Li Z
Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
[TBL] [Abstract][Full Text] [Related]
14. Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren's syndrome.
Wen J; Zhu F; Yu X; Xie H; Li C
BMC Immunol; 2022 Oct; 23(1):49. PubMed ID: 36244973
[TBL] [Abstract][Full Text] [Related]
15. Total glucosides of paeony (TGP) alleviates Sjogren's syndrome through inhibiting inflammatory responses in mice.
Li B; Liu G; Liu R; He S; Li X; Huang L; Wang Z; Li Y; Chen Y; Yin H; Fang W
Phytomedicine; 2020 Jun; 71():153203. PubMed ID: 32402913
[TBL] [Abstract][Full Text] [Related]
16. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.
Sakai A; Sugawara Y; Kuroishi T; Sasano T; Sugawara S
J Immunol; 2008 Aug; 181(4):2898-906. PubMed ID: 18684981
[TBL] [Abstract][Full Text] [Related]
17. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
Contreras Ruiz L; Mir FA; Turpie B; Masli S
Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
[TBL] [Abstract][Full Text] [Related]
19. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
[TBL] [Abstract][Full Text] [Related]
20. Paeoniflorin ameliorates symptoms of experimental Sjogren's syndrome associated with down-regulating Cyr61 expression.
Li H; Sun X; Zhang J; Sun Y; Huo R; Li H; Zhai T; Shen B; Zhang M; Li N
Int Immunopharmacol; 2016 Jan; 30():27-35. PubMed ID: 26630293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
